Search

everythinglearnresearchcommunity

for

Search:↓

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

CO2 fractional laser treatment helped regrow hair in a 13-year-old with alopecia areata.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.

Low-dose spironolactone effectively treats female pattern hair loss with mild side effects.

PRP-based treatments can increase hair density, but results vary among individuals.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Bone marrow cells improved tendon health better than platelet-rich plasma.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.